As well as stimulating insulin release, GLP-1R agonists promote satiety and reduce food intake, leading to weight loss
Continued Growth in GLP-1 Compounding Despite Regulatory Headwinds Despite the resolution of GLP-1 shortages and increased regulatory scrutiny, compounded prescriptions for semaglutide and tirzepatide continue to rise
Table of Contents How GLP-1 Medications Affect Taste and Food Preferences Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), are increasingly prescribed for type 2 diabetes management and weight loss
This latest shift, while significant, is not out of the ordinary
What high B12 means If your B12 is elevated because of supplements or injections, its usually harmless